25 XP   0   0   10

Rezolute Inc
Buy, Hold or Sell?

Let's analyse Rezolute Inc together

PenkeI guess you are interested in Rezolute Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rezolute Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Rezolute Inc

I send you an email if I find something interesting about Rezolute Inc.

Quick analysis of Rezolute Inc (30 sec.)










What can you expect buying and holding a share of Rezolute Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.78
Expected worth in 1 year
$0.82
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.96
Return On Investment
-33.3%

For what price can you sell your share?

Current Price per Share
$2.89
Expected price per share
$2.29 - $4
How sure are you?
50%

1. Valuation of Rezolute Inc (5 min.)




Live pricePrice per Share (EOD)

$2.89

Intrinsic Value Per Share

$-10.94 - $-8.64

Total Value Per Share

$-9.16 - $-6.85

2. Growth of Rezolute Inc (5 min.)




Is Rezolute Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$91.7m$123.9m-$14.2m-13.0%

How much money is Rezolute Inc making?

Current yearPrevious yearGrowGrow %
Making money-$14.2m-$10.4m-$3.7m-26.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Rezolute Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#382 / 1010

Most Revenue
#854 / 1010

Most Profit
#626 / 1010

Most Efficient
#301 / 1010

What can you expect buying and holding a share of Rezolute Inc? (5 min.)

Welcome investor! Rezolute Inc's management wants to use your money to grow the business. In return you get a share of Rezolute Inc.

What can you expect buying and holding a share of Rezolute Inc?

First you should know what it really means to hold a share of Rezolute Inc. And how you can make/lose money.

Speculation

The Price per Share of Rezolute Inc is $2.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rezolute Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rezolute Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.78. Based on the TTM, the Book Value Change Per Share is $-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is $0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rezolute Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.27-9.4%-0.28-9.6%-0.24-8.5%-0.21-7.4%-0.17-5.7%
Usd Book Value Change Per Share-0.23-8.0%-0.24-8.3%0.2910.2%0.103.5%0.051.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-8.0%-0.24-8.3%0.2910.2%0.103.5%0.051.6%
Usd Price Per Share0.99-1.55-2.86-3.22-2.19-
Price to Earnings Ratio-0.92--1.41--2.97--4.55--3.96-
Price-to-Total Gains Ratio-4.31--6.48--5.66--17.10--0.57-
Price to Book Ratio0.56-0.72-1.27-3.96-7.08-
Price-to-Total Gains Ratio-4.31--6.48--5.66--17.10--0.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.89
Number of shares346
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.240.10
Usd Total Gains Per Share-0.240.10
Gains per Quarter (346 shares)-83.3435.14
Gains per Year (346 shares)-333.37140.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-333-3430141131
20-667-6760281272
30-1000-10090422413
40-1333-13420562554
50-1667-16750703695
60-2000-20080843836
70-2334-23410984977
80-2667-2674011251118
90-3000-3007012651259
100-3334-3340014061400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.050.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.014.01.025.0%12.026.02.030.0%14.033.03.028.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.050.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.014.01.025.0%12.026.02.030.0%14.033.03.028.0%

Fundamentals of Rezolute Inc

About Rezolute Inc

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-04-12 17:46:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Rezolute Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Rezolute Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rezolute Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Rezolute Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • -13.6% Return on Assets means that Rezolute Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rezolute Inc:

  • The MRQ is -13.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.6%TTM-12.1%-1.5%
TTM-12.1%YOY-9.0%-3.1%
TTM-12.1%5Y-23.4%+11.3%
5Y-23.4%10Y-80.4%+57.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.6%-13.3%-0.3%
TTM-12.1%-12.8%+0.7%
YOY-9.0%-11.7%+2.7%
5Y-23.4%-13.9%-9.5%
10Y-80.4%-15.7%-64.7%
1.1.3. Return on Equity

Shows how efficient Rezolute Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • -15.2% Return on Equity means Rezolute Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rezolute Inc:

  • The MRQ is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-13.1%-2.0%
TTM-13.1%YOY-10.6%-2.5%
TTM-13.1%5Y-51.4%+38.3%
5Y-51.4%10Y-82.6%+31.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.2%-16.9%+1.7%
TTM-13.1%-16.1%+3.0%
YOY-10.6%-15.1%+4.5%
5Y-51.4%-19.3%-32.1%
10Y-82.6%-20.2%-62.4%

1.2. Operating Efficiency of Rezolute Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rezolute Inc is operating .

  • Measures how much profit Rezolute Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rezolute Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Rezolute Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rezolute Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Rezolute Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rezolute Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.00 means the company has $12.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rezolute Inc:

  • The MRQ is 11.999. The company is very able to pay all its short-term debts. +2
  • The TTM is 17.624. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.999TTM17.624-5.625
TTM17.624YOY42.896-25.273
TTM17.6245Y16.791+0.833
5Y16.79110Y9.541+7.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9993.890+8.109
TTM17.6244.173+13.451
YOY42.8965.344+37.552
5Y16.7916.126+10.665
10Y9.5416.448+3.093
1.3.2. Quick Ratio

Measures if Rezolute Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • A Quick Ratio of 21.56 means the company can pay off $21.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rezolute Inc:

  • The MRQ is 21.565. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 30.822. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ21.565TTM30.822-9.257
TTM30.822YOY42.476-11.654
TTM30.8225Y19.058+11.764
5Y19.05810Y10.602+8.456
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.5653.514+18.051
TTM30.8223.998+26.824
YOY42.4765.380+37.096
5Y19.0586.105+12.953
10Y10.6026.404+4.198

1.4. Solvency of Rezolute Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rezolute Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rezolute Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Rezolute Inc assets are financed with 10.2% credit (debt) and the remaining percentage (100% - 10.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Rezolute Inc:

  • The MRQ is 0.102. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.074. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.074+0.028
TTM0.074YOY0.088-0.013
TTM0.0745Y0.247-0.173
5Y0.24710Y0.956-0.708
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1020.339-0.237
TTM0.0740.336-0.262
YOY0.0880.271-0.183
5Y0.2470.366-0.119
10Y0.9560.389+0.567
1.4.2. Debt to Equity Ratio

Measures if Rezolute Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rezolute Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.4% means that company has $0.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rezolute Inc:

  • The MRQ is 0.114. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.081. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.081+0.033
TTM0.081YOY0.111-0.030
TTM0.0815Y0.658-0.577
5Y0.65810Y0.864-0.206
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1140.388-0.274
TTM0.0810.402-0.321
YOY0.1110.335-0.224
5Y0.6580.426+0.232
10Y0.8640.461+0.403

2. Market Valuation of Rezolute Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rezolute Inc generates.

  • Above 15 is considered overpriced but always compare Rezolute Inc to the Biotechnology industry mean.
  • A PE ratio of -0.92 means the investor is paying $-0.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rezolute Inc:

  • The EOD is -2.670. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.917. Based on the earnings, the company is expensive. -2
  • The TTM is -1.415. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.670MRQ-0.917-1.753
MRQ-0.917TTM-1.415+0.498
TTM-1.415YOY-2.967+1.552
TTM-1.4155Y-4.547+3.132
5Y-4.54710Y-3.962-0.585
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.670-2.264-0.406
MRQ-0.917-2.629+1.712
TTM-1.415-2.680+1.265
YOY-2.967-4.145+1.178
5Y-4.547-6.257+1.710
10Y-3.962-6.254+2.292
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rezolute Inc:

  • The EOD is -2.853. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.980. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.556. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.853MRQ-0.980-1.873
MRQ-0.980TTM-1.556+0.576
TTM-1.556YOY-3.268+1.712
TTM-1.5565Y-4.952+3.396
5Y-4.95210Y-4.728-0.224
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.853-2.973+0.120
MRQ-0.980-3.333+2.353
TTM-1.556-3.553+1.997
YOY-3.268-5.605+2.337
5Y-4.952-8.376+3.424
10Y-4.728-8.865+4.137
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Rezolute Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.56 means the investor is paying $0.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rezolute Inc:

  • The EOD is 1.620. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.556. Based on the equity, the company is cheap. +2
  • The TTM is 0.716. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.620MRQ0.556+1.063
MRQ0.556TTM0.716-0.160
TTM0.716YOY1.274-0.558
TTM0.7165Y3.956-3.240
5Y3.95610Y7.080-3.124
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6201.896-0.276
MRQ0.5562.115-1.559
TTM0.7162.093-1.377
YOY1.2742.884-1.610
5Y3.9563.542+0.414
10Y7.0803.916+3.164
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Rezolute Inc.

3.1. Institutions holding Rezolute Inc

Institutions are holding 77.817% of the shares of Rezolute Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Federated Hermes Inc25.62590.02510154327354405353.6143
2023-12-31Vivo Capital, LLC8.18380.263532428422758403569.4015
2023-12-31Nantahala Capital Management, LLC7.76120.091330754142305808299.6089
2023-12-31Stonepine Capital Management Llc6.98711.18842768656-303820-9.8884
2023-12-31First Manhattan Co. LLC6.76580.00922680978-942100-26.0028
2023-12-31Blackstone Inc3.88060.0069153768400
2023-12-31Vanguard Group Inc3.55240140765200
2023-12-31Caxton Corp3.32867.0668131896700
2023-12-31Sphera Funds Management Ltd.2.51530.159299671000
2023-12-31Adage Capital Partners Gp LLC1.59420.001363169000
2023-12-31UBS O'Connor LLC1.51740.0429601259439527.8865
2023-12-31CVI Holdings LLC0.90090.7325356978-124798-25.9037
2023-09-30Citadel Advisors Llc0.79810.0001316264-11574-3.5304
2023-12-31Geode Capital Management, LLC0.6628026264900
2023-12-31BlackRock Inc0.6615026212135041.3549
2023-12-31UBS Group AG0.54990.00012179022179020
2023-09-30Bvf Inc0.48150.006819081500
2023-12-31SILVERARC CAPITAL MANAGEMENT, LLC0.39640.0464157085-276155-63.7418
2023-12-31Northern Trust Corp0.212083986-1923-2.2384
2023-12-31State Street Corporation0.150305957200
Total 76.52579.640430323551+7213252+23.8%

3.2. Funds holding Rezolute Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Federated Hermes Kaufmann Small Cap Grow8.35530.0782331080000
2023-12-31Federated Hermes Kaufmann Small Cap A8.35530.0781331080000
2023-12-31Federated Hermes Kaufmann Growth8.11430.0655321530000
2023-12-31Federated Hermes Kaufmann R8.11430.0654321530000
2024-02-29Vanguard Total Stock Mkt Idx Inv2.5140.000199617400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.29290.000851231400
2024-02-29Fidelity Extended Market Index0.35740.0006141624-686-0.482
2023-12-31Federated Hermes Kaufmann II P0.21240.06768417400
2024-03-31BlackRock Extended Equity Market K0.20780.001482327823270
2024-03-28iShares Micro-Cap ETF0.16710.01846619700
2024-02-29Fidelity Total Market Index0.1380.00015469700
2023-11-30MEDICAL BioHealth EUR Acc0.12650.005850116-95956-65.6909
2024-02-29Fidelity Series Total Market Index0.09280.00013677300
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.08410.000133333-808641-96.0411
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.08410.00023333300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06770.00042683100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05990.00042373100
2023-12-31Northern Trust Extended Eq Market Idx0.05990.00042373100
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05440.000421549400.186
2024-02-29Schwab Total Stock Market Index0.03470.00011375700
Total 38.49290.384115252861-822916-5.4%

3.3. Insider Transactions

Insiders are holding 20.454% of the shares of Rezolute Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-28Brian Kenneth RobertsBUY5002.55
2024-03-15Daron EvansBUY200001.69
2024-03-14Brian Kenneth RobertsBUY100001.88
2024-03-08Daron EvansBUY500001.93
2024-03-07Brian Kenneth RobertsBUY5001.85
2024-03-07Young-jin KimBUY365031.91
2024-02-26Brian Kenneth RobertsBUY20001.7
2024-02-26Nevan C ElamBUY50001.68
2024-02-23Brian Kenneth RobertsBUY60001.69
2024-02-16Brian Kenneth RobertsBUY70001.31
2024-02-16Daron EvansBUY419001.3
2023-07-03Brian Kenneth RobertsBUY50001.9

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Rezolute Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.230-0.241+5%0.294-178%0.102-327%0.047-586%
Book Value Per Share--1.7842.134-16%2.715-34%1.275+40%0.694+157%
Current Ratio--11.99917.624-32%42.896-72%16.791-29%9.541+26%
Debt To Asset Ratio--0.1020.074+37%0.088+16%0.247-59%0.956-89%
Debt To Equity Ratio--0.1140.081+40%0.111+3%0.658-83%0.864-87%
Dividend Per Share----0%-0%-0%-0%
Eps---0.271-0.276+2%-0.245-10%-0.214-21%-0.166-39%
Free Cash Flow Per Share---0.253-0.257+1%-0.239-6%-0.189-25%-0.131-48%
Free Cash Flow To Equity Per Share---0.259-0.2580%0.412-163%0.275-194%0.140-285%
Gross Profit Margin--1.0011.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---8.638--------
Intrinsic Value_10Y_min---10.942--------
Intrinsic Value_1Y_max---0.575--------
Intrinsic Value_1Y_min---0.910--------
Intrinsic Value_3Y_max---1.950--------
Intrinsic Value_3Y_min---2.912--------
Intrinsic Value_5Y_max---3.591--------
Intrinsic Value_5Y_min---5.093--------
Market Cap114517117.000+55%51022440.00079844850.000-36%126697163.250-60%134101939.558-62%90203840.708-43%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.620+66%0.5560.716-22%1.274-56%3.956-86%7.080-92%
Pe Ratio-2.670-191%-0.917-1.415+54%-2.967+223%-4.547+396%-3.962+332%
Price Per Share2.890+66%0.9931.553-36%2.855-65%3.223-69%2.192-55%
Price To Free Cash Flow Ratio-2.853-191%-0.980-1.556+59%-3.268+234%-4.952+405%-4.728+383%
Price To Total Gains Ratio-12.554-191%-4.312-6.476+50%-5.663+31%-17.098+297%-0.575-87%
Quick Ratio--21.56530.822-30%42.476-49%19.058+13%10.602+103%
Return On Assets---0.136-0.121-11%-0.090-34%-0.234+72%-0.804+490%
Return On Equity---0.152-0.131-14%-0.106-30%-0.514+239%-0.826+444%
Total Gains Per Share---0.230-0.241+5%0.294-178%0.102-327%0.047-586%
Usd Book Value--91728000.000109695000.000-16%123933250.000-26%58810880.800+56%31640197.000+190%
Usd Book Value Change Per Share---0.230-0.241+5%0.294-178%0.102-327%0.047-586%
Usd Book Value Per Share--1.7842.134-16%2.715-34%1.275+40%0.694+157%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.271-0.276+2%-0.245-10%-0.214-21%-0.166-39%
Usd Free Cash Flow---13020000.000-13212750.000+1%-10328250.000-21%-8255308.850-37%-5604399.725-57%
Usd Free Cash Flow Per Share---0.253-0.257+1%-0.239-6%-0.189-25%-0.131-48%
Usd Free Cash Flow To Equity Per Share---0.259-0.2580%0.412-163%0.275-194%0.140-285%
Usd Market Cap114517117.000+55%51022440.00079844850.000-36%126697163.250-60%134101939.558-62%90203840.708-43%
Usd Price Per Share2.890+66%0.9931.553-36%2.855-65%3.223-69%2.192-55%
Usd Profit---13909000.000-14211750.000+2%-10442250.000-25%-9156316.750-34%-7082694.400-49%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.230-0.241+5%0.294-178%0.102-327%0.047-586%
 EOD+5 -3MRQTTM+14 -16YOY+4 -265Y+12 -1810Y+12 -18

4.2. Fundamental Score

Let's check the fundamental score of Rezolute Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.670
Price to Book Ratio (EOD)Between0-11.620
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than121.565
Current Ratio (MRQ)Greater than111.999
Debt to Asset Ratio (MRQ)Less than10.102
Debt to Equity Ratio (MRQ)Less than10.114
Return on Equity (MRQ)Greater than0.15-0.152
Return on Assets (MRQ)Greater than0.05-0.136
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Rezolute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.236
Ma 20Greater thanMa 502.752
Ma 50Greater thanMa 1002.136
Ma 100Greater thanMa 2001.556
OpenGreater thanClose2.860
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets102,150
Total Liabilities10,422
Total Stockholder Equity91,728
 As reported
Total Liabilities 10,422
Total Stockholder Equity+ 91,728
Total Assets = 102,150

Assets

Total Assets102,150
Total Current Assets96,085
Long-term Assets6,065
Total Current Assets
Cash And Cash Equivalents 12,504
Short-term Investments 80,094
Other Current Assets 3,487
Total Current Assets  (as reported)96,085
Total Current Assets  (calculated)96,085
+/-0
Long-term Assets
Property Plant Equipment 2,249
Long Term Investments 3,352
Long-term Assets Other 464
Long-term Assets  (as reported)6,065
Long-term Assets  (calculated)6,065
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,008
Long-term Liabilities2,414
Total Stockholder Equity91,728
Total Current Liabilities
Short-term Debt 538
Accounts payable 3,593
Other Current Liabilities 3,877
Total Current Liabilities  (as reported)8,008
Total Current Liabilities  (calculated)8,008
+/- 0
Long-term Liabilities
Capital Lease Obligations 2,513
Long-term Liabilities  (as reported)2,414
Long-term Liabilities  (calculated)2,513
+/- 99
Total Stockholder Equity
Common Stock40
Retained Earnings -289,418
Accumulated Other Comprehensive Income -48
Other Stockholders Equity 381,154
Total Stockholder Equity (as reported)91,728
Total Stockholder Equity (calculated)91,728
+/-0
Other
Capital Stock40
Cash and Short Term Investments 92,598
Common Stock Shares Outstanding 51,408
Current Deferred Revenue0
Liabilities and Stockholders Equity 102,150
Net Debt -9,991
Net Invested Capital 91,728
Net Working Capital 88,077
Property Plant and Equipment Gross 2,249
Short Long Term Debt Total 2,513



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-31
> Total Assets 
0
23
16
9
5
5
0
1,568
1,104
864
2,146
6,270
7,405
6,267
10,723
12,056
11,263
9,170
8,535
8,791
10,903
10,057
9,938
10,795
10,629
9,797
6,321
5,141
2,503
2,503
456
15,464
12,252
26,572
20,565
14,701
10,965
10,965
38,902
32,933
42,609
38,760
83,405
69,573
152,420
155,988
150,208
134,205
123,721
112,999
102,150
102,150112,999123,721134,205150,208155,988152,42069,57383,40538,76042,60932,93338,90210,96510,96514,70120,56526,57212,25215,4644562,5032,5035,1416,3219,79710,62910,7959,93810,05710,9038,7918,5359,17011,26312,05610,7236,2677,4056,2702,1468641,1041,568055916230
   > Total Current Assets 
0
23
16
7
5
5
0
1,279
816
576
1,859
5,984
6,308
4,696
8,733
8,942
6,116
3,055
1,843
2,040
4,492
3,730
3,787
4,850
4,929
4,365
1,164
446
2,008
2,008
422
15,358
12,144
25,916
19,969
14,166
10,518
10,518
38,154
32,195
41,993
38,345
78,098
64,331
152,104
155,627
147,606
105,526
104,910
102,645
96,085
96,085102,645104,910105,526147,606155,627152,10464,33178,09838,34541,99332,19538,15410,51810,51814,16619,96925,91612,14415,3584222,0082,0084461,1644,3654,9294,8503,7873,7304,4922,0401,8433,0556,1168,9428,7334,6966,3085,9841,8595768161,279055716230
       Cash And Cash Equivalents 
0
23
16
7
5
5
0
394
1
1
1,145
5,642
5,935
4,298
8,590
8,225
5,279
2,353
1,708
1,746
4,062
3,366
3,573
4,437
4,487
4,016
868
78
1,646
1,646
258
15,344
11,573
22,104
18,182
14,033
9,955
9,955
37,600
31,989
41,047
37,292
77,403
63,416
150,410
154,322
146,746
33,743
16,036
8,057
12,504
12,5048,05716,03633,743146,746154,322150,41063,41677,40337,29241,04731,98937,6009,9559,95514,03318,18222,10411,57315,3442581,6461,646788684,0164,4874,4373,5733,3664,0621,7461,7082,3535,2798,2258,5904,2985,9355,6421,14511394055716230
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
450
450
450
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,319
85,860
90,673
80,094
80,09490,67385,86069,31900000000000000000000000000000450450450000000000000000
       Net Receivables 
0
0
0
0
0
0
0
292
351
232
339
0
0
0
0
450
450
450
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000024700000000000000045045045000003392323512920000000
       Other Current Assets 
0
0
0
0
0
0
0
370
95
50
14
120
83
96
67
175
320
65
135
294
430
364
213
413
442
349
296
368
362
362
92
14
571
3,565
1,787
133
0
563
554
206
946
1,053
695
915
1,694
1,305
860
2,464
3,014
3,915
3,487
3,4873,9153,0142,4648601,3051,6949156951,05394620655456301331,7873,5655711492362362368296349442413213364430294135653201756796831201450953700000000
   > Long-term Assets 
0
0
0
2
0
0
0
289
288
288
287
286
1,097
1,571
1,990
3,114
5,147
6,116
6,691
6,751
6,411
6,327
6,152
5,945
5,700
5,432
5,158
4,695
0
495
33
106
108
656
596
535
447
447
748
738
616
415
5,307
5,242
316
361
2,602
28,679
18,811
10,354
6,065
6,06510,35418,81128,6792,6023613165,2425,3074156167387484474475355966561081063349504,6955,1585,4325,7005,9456,1526,3276,4116,7516,6916,1165,1473,1141,9901,5711,0972862872882882890002000
       Property Plant Equipment 
0
0
0
0
0
0
0
276
276
276
276
276
338
812
1,178
2,303
4,525
5,496
6,073
6,135
5,985
5,902
5,729
5,461
5,325
5,065
4,798
4,531
368
368
368
40
44
593
535
476
416
416
583
505
425
343
259
194
168
213
2,454
2,321
2,193
2,062
2,249
2,2492,0622,1932,3212,45421316819425934342550558341641647653559344403683683684,5314,7985,0655,3255,4615,7295,9025,9856,1356,0735,4964,5252,3031,1788123382762762762762760000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,210
16,470
8,144
3,352
3,3528,14416,47026,21000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
2
0
0
0
13
13
12
11
10
9
9
63
61
59
57
55
53
52
50
48
46
44
42
41
39
37
35
33
31,561
29
28
26
24
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002426282931,56133353739414244464850525355575961639910111213130002000
       Other Assets 
0
0
0
0
0
0
0
13
13
12
11
10
759
759
813
811
622
619
619
616
427
425
423
484
375
367
360
126
90
82
0
35
35
35
35
35
31
160
165
233
191
72
5,048
5,048
0
148
148
0
148
0
0
00148014814805,0485,048721912331651603135353535350829012636036737548442342542761661961962281181375975910111213130000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48
0
0
0
0
0
0
0
0000000480000000000000000000000000000000000000000000
> Total Liabilities 
0
5
6
9
11
11
24
5,118
5,266
5,680
6,543
2,862
998
1,248
2,906
2,352
2,209
2,413
4,757
7,672
2,131
1,854
2,006
2,335
2,101
1,991
2,520
4,608
6,464
6,464
10,243
10,815
10,500
5,954
5,877
4,375
3,600
3,600
3,016
3,801
16,510
17,201
21,140
17,666
2,949
2,898
8,943
6,889
7,549
9,435
10,422
10,4229,4357,5496,8898,9432,8982,94917,66621,14017,20116,5103,8013,0163,6003,6004,3755,8775,95410,50010,81510,2436,4646,4644,6082,5201,9912,1012,3352,0061,8542,1317,6724,7572,4132,2092,3522,9061,2489982,8626,5435,6805,2665,1182411119650
   > Total Current Liabilities 
0
5
6
9
11
11
24
5,118
5,266
5,680
6,543
2,862
964
893
2,371
1,798
1,706
1,959
2,492
2,419
1,731
1,487
1,670
2,020
1,771
1,692
2,251
4,371
6,248
6,248
2,976
6,624
8,379
5,523
5,542
3,530
3,226
3,226
2,735
3,588
1,968
2,598
6,445
2,878
2,462
2,429
6,313
4,387
5,200
7,195
8,008
8,0087,1955,2004,3876,3132,4292,4622,8786,4452,5981,9683,5882,7353,2263,2263,5305,5425,5238,3796,6242,9766,2486,2484,3712,2511,6921,7712,0201,6701,4871,7312,4192,4921,9591,7061,7982,3718939642,8626,5435,6805,2665,1182411119650
       Short-term Debt 
0
0
0
0
0
0
0
3,733
3,733
3,733
4,800
2,015
60
143
152
153
154
154
131
107
83
60
10
10
10
10
10
925
3,435
3,435
10
10
10
234
239
245
0
245
316
321
265
206
147
107
108
112
167
319
541
525
538
53852554131916711210810714720626532131624502452392341010103,4353,43592510101010106083107131154154153152143602,0154,8003,7333,7333,7330000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
10
925
3,435
0
10
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000010101003,4359251010101000000000000000000000000
       Accounts payable 
0
5
6
9
11
11
9
775
188
409
477
646
460
320
875
1,326
1,408
1,671
2,216
2,169
1,501
1,286
1,531
1,888
1,653
1,568
2,122
3,209
1,706
1,706
2,091
954
1,051
1,320
1,253
1,257
893
893
612
811
1,035
1,592
4,349
1,557
1,132
1,110
2,841
2,947
3,269
2,432
3,593
3,5932,4323,2692,9472,8411,1101,1321,5574,3491,5921,0358116128938931,2571,2531,3201,0519542,0911,7061,7063,2092,1221,5681,6531,8881,5311,2861,5012,1692,2161,6711,4081,326875320460646477409188775911119650
       Other Current Liabilities 
0
0
0
0
0
0
16
312
158
115
664
103
36
414
1,145
307
130
121
17
129
132
125
126
0
1
0
116
93
188
74
875
5,659
7,318
3,969
4,050
2,028
0
2,088
1,807
1,807
668
800
1,949
1,214
1,222
1,207
3,305
1,121
1,390
4,238
3,877
3,8774,2381,3901,1213,3051,2071,2221,2141,9498006681,8071,8072,08802,0284,0503,9697,3185,6598757418893116010126125132129171211303071,1454143610366411515831216000000
   > Long-term Liabilities 
0
5
6
9
0
11
9
4,508
3,921
4,141
5,278
2,661
34
355
535
553
504
454
2,264
5,253
400
368
336
315
330
299
269
237
0
216
7,267
4,191
2,121
431
335
845
374
374
281
213
14,542
14,603
14,695
14,788
487
469
2,630
2,502
2,349
2,240
2,414
2,4142,2402,3492,5022,63046948714,78814,69514,60314,5422132813743748453354312,1214,1917,26721602372692993303153363684005,2532,264454504553535355342,6615,2784,1413,9214,50891109650
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,681
407
0
434
447
0
0
0
000447434040714,6810000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48
0
0
0
0
0
0
0
0000000480000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
34
253
464
507
480
453
461
431
400
367
335
315
330
299
268
237
216
173
2,261
4,191
2,121
85
48
621
209
0
0
0
387
371
383
395
407
420
434
0
412
0
0
00412043442040739538337138700020962148852,1214,1912,26117321623726829933031533536740043146145348050746425334000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315
305
274
244
212
0
0
0
0
0
0
0
0
0
129
122
221
191
72
48
48
0
0
0
0
0
0
0
000000048487219122112212900000000021224427430531500000000000000000000000
> Total Stockholder Equity
0
18
10
0
-5
-5
-24
-3,550
-4,162
-4,816
-4,397
3,408
6,407
5,019
7,817
9,704
9,054
6,758
3,778
1,119
8,773
8,202
7,933
8,460
8,528
7,806
3,802
533
-3,961
-3,961
-9,788
4,650
1,752
20,618
14,688
10,326
7,365
7,365
35,886
29,132
26,099
21,559
62,265
51,907
149,471
153,090
141,265
127,316
116,172
103,564
91,728
91,728103,564116,172127,316141,265153,090149,47151,90762,26521,55926,09929,13235,8867,3657,36510,32614,68820,6181,7524,650-9,788-3,961-3,9615333,8027,8068,5288,4607,9338,2028,7731,1193,7786,7589,0549,7047,8175,0196,4073,408-4,397-4,816-4,162-3,550-24-5-5010180
   Common Stock
0
4
4
4
4
4
25
40
40
40
40
15
18
18
22
24
24
24
24
24
35
38
41
45
49
54
54
54
62
62
62
62
210
293
293
293
6
6
8
8
8
9
16
16
34
37
37
37
37
37
40
4037373737373416169888662932932932106262626254545449454138352424242424221818154040404025444440
   Retained Earnings Total Equity000-248,257-232,5850-209,198-199,7750000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income -48-284-351-132000000000-14,000-14,00000-3-3-1-518-518-518-2,786-2,520-2,253-1,986-1,709-1,426-1,148-879-612-356-206-137000-8000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,666
358,635
0
373,813
375,668
0
0
0
000375,668373,8130358,635251,6660000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
63
63
63
82
82
61
3,397
3,814
3,980
6,218
19,135
24,143
24,962
30,692
35,750
38,275
39,336
40,573
37,059
53,662
57,173
62,066
68,257
74,787
81,011
82,992
84,958
0
90,679
91,861
97,204
128,448
152,308
153,044
153,722
0
168,595
193,831
190,772
194,229
197,524
250,816
251,666
358,635
372,082
373,813
375,668
377,471
379,320
381,154
381,154379,320377,471375,668373,813372,082358,635251,666250,816197,524194,229190,772193,831168,5950153,722153,044152,308128,44897,20491,86190,679084,95882,99281,01174,78768,25762,06657,17353,66237,05940,57339,33638,27535,75030,69224,96224,14319,1356,2183,9803,8143,3976182826363630



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-382
Gross Profit-382-382
 
Operating Income (+$)
Gross Profit-382
Operating Expense-55,990
Operating Income-55,990-56,372
 
Operating Expense (+$)
Research Development43,813
Selling General Administrative12,177
Selling And Marketing Expenses0
Operating Expense55,99055,990
 
Net Interest Income (+$)
Interest Income4,208
Interest Expense-919
Other Finance Cost-919
Net Interest Income4,208
 
Pretax Income (+$)
Operating Income-55,990
Net Interest Income4,208
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-51,787-55,985
EBIT - interestExpense = -52,701
-51,787
-50,868
Interest Expense919
Earnings Before Interest and Taxes (EBIT)-51,782-50,868
Earnings Before Interest and Taxes (EBITDA)-51,752
 
After tax Income (+$)
Income Before Tax-51,787
Tax Provision-0
Net Income From Continuing Ops-51,787-51,787
Net Income-51,787
Net Income Applicable To Common Shares-51,787
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses55,990
Total Other Income/Expenses Net-5-4,208
 

Technical Analysis of Rezolute Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rezolute Inc. The general trend of Rezolute Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rezolute Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Rezolute Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.

The bearish price targets are: 2.73 > 2.685 > 2.29.

Tweet this
Rezolute Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rezolute Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Rezolute Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rezolute Inc. The current macd is 0.32399614.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Rezolute Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Rezolute Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Rezolute Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Rezolute Inc Daily Moving Average Convergence/Divergence (MACD) ChartRezolute Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Rezolute Inc. The current adx is 59.28.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Rezolute Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Rezolute Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rezolute Inc. The current sar is 3.69.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Rezolute Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rezolute Inc. The current rsi is 56.24. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Rezolute Inc Daily Relative Strength Index (RSI) ChartRezolute Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rezolute Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Rezolute Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Rezolute Inc Daily Stochastic Oscillator ChartRezolute Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rezolute Inc. The current cci is 21.75.

Rezolute Inc Daily Commodity Channel Index (CCI) ChartRezolute Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rezolute Inc. The current cmo is 2.44137965.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Rezolute Inc Daily Chande Momentum Oscillator (CMO) ChartRezolute Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Rezolute Inc. The current willr is -57.9752156.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Rezolute Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Rezolute Inc Daily Williams %R ChartRezolute Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Rezolute Inc.

Rezolute Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rezolute Inc. The current atr is 0.34306222.

Rezolute Inc Daily Average True Range (ATR) ChartRezolute Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rezolute Inc. The current obv is 10,872,844.

Rezolute Inc Daily On-Balance Volume (OBV) ChartRezolute Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rezolute Inc. The current mfi is 64.79.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Rezolute Inc Daily Money Flow Index (MFI) ChartRezolute Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Rezolute Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Rezolute Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Rezolute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.236
Ma 20Greater thanMa 502.752
Ma 50Greater thanMa 1002.136
Ma 100Greater thanMa 2001.556
OpenGreater thanClose2.860
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Rezolute Inc with someone you think should read this too:
  • Are you bullish or bearish on Rezolute Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Rezolute Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Rezolute Inc

I send you an email if I find something interesting about Rezolute Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Rezolute Inc.

Receive notifications about Rezolute Inc in your mailbox!